Spotlight
Memorials
Classifieds
Families First
VCAs
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Program
Breaking on FOX 50 at 10: Three more players leaving UNC football program. What we know about their departures.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Landos Biopharma, Inc.
Landos Biopharma Announces Transfer of LANCL Portfolio, including Omilancor, LABP-104 and LABP-111 to Landos’ Founder
February 28, 2023
From
Landos Biopharma, Inc.
Via
GlobeNewswire
Tickers
LABP
Landos Biopharma Announces Acceptance of Abstract on NX-13 Phase 1b Study in Ulcerative Colitis at 18th Annual Congress of the European Crohn’s and Colitis Organization
January 11, 2023
From
Landos Biopharma, Inc.
Via
GlobeNewswire
Tickers
LABP
Landos Biopharma Provides Comprehensive Update on Clinical Development Plans
January 05, 2023
From
Landos Biopharma, Inc.
Via
GlobeNewswire
Tickers
LABP
Landos Biopharma Announces $16.7 Million Private Placement Financing
January 05, 2023
From
Landos Biopharma, Inc.
Via
GlobeNewswire
Tickers
LABP
Landos Biopharma Reports Third Quarter 2022 Results and Provides Business Update
November 10, 2022
From
Landos Biopharma, Inc.
Via
GlobeNewswire
Tickers
LABP
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.